Peritoneal Dialysis Market Size, Share, Growth, And Industry Analysis By Type (Peritoneal Dialysis Machine, Peritoneal Dialysis Solution and Others) By Application (CAPD, APD and Others), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

PERITONEAL DIALYSIS MARKET OVERVIEW

The global Peritoneal Dialysis Market is anticipated to be worth USD 0.17 Billion in 2026. It is expected to grow steadily and reach USD 0.29 Billion by 2035. This growth represents a CAGR of 6.1% during the forecast period from 2026 to 2035.

The peritoneal dialysis market covers machines, dialysis solutions, transfer sets, catheters, cyclers, and related supplies used to provide kidney replacement therapy through the peritoneal membrane. Peritoneal dialysis supports home-based treatment and reduces dependence on facility-based hemodialysis infrastructure. Continuous ambulatory peritoneal dialysis and automated peritoneal dialysis are the principal treatment approaches. Solutions represent approximately 55% of product demand because every exchange requires sterile dialysate. Automated systems are gaining adoption through remote monitoring, prescription management, and connected cyclers. Market development is supported by rising kidney failure prevalence, home-care policies, patient preference for treatment flexibility, and improvements in infection-prevention technology.

The USA peritoneal dialysis market is supported by established nephrology networks, home-dialysis reimbursement, clinical training programs, and growing interest in patient-centered kidney care. Providers are strengthening home assessment, catheter placement coordination, patient education, and remote treatment monitoring. Automated peritoneal dialysis is preferred by many suitable patients because exchanges can be completed overnight. Market demand includes cyclers, glucose-based solutions, transfer sets, drain accessories, disinfecting products, and digital care platforms. However, adoption varies because patients require appropriate housing, storage capacity, caregiver support, manual ability, and reliable clinical follow-up. Manufacturers compete through connected equipment, simplified operation, dependable supply delivery, technical support, and compatibility with home-care workflows.

KEY FINDINGS

Latest Trends

Market Demand To Increase Due To The Growing Adoption Of APD

The peritoneal dialysis market is shifting toward connected home therapy, simplified equipment, individualized prescriptions, and stronger clinical oversight. Automated peritoneal dialysis cyclers increasingly include guided setup, treatment records, alarm management, prescription transfer, and remote data-sharing capabilities. These functions allow clinicians to review adherence, ultrafiltration, drain performance, and treatment interruptions without requiring every interaction to occur at a dialysis center. Connected features are involved in approximately 44% of current technology upgrades.

Home-first kidney care policies are encouraging hospitals and dialysis providers to improve patient education, catheter placement, urgent-start programs, and home suitability assessments. Manufacturers are developing lighter cyclers, smaller consumable packages, clearer user interfaces, and quieter pumping systems. Approximately 36% of product innovation centers on simplifying patient operation and reducing training complexity.

Biocompatible solutions are another important trend. Providers are evaluating neutral-pH formulations, low glucose-degradation-product solutions, icodextrin-based fluids, and treatment regimens designed to improve fluid management. Infection prevention remains central to product design, driving demand for closed connections, touch-contamination safeguards, antimicrobial catheter strategies, and improved transfer sets.

• According to the U.S. Centers for Disease Control and Prevention (CDC), about 15% of U.S. adults—37 million people—have chronic kidney disease, driving higher adoption of automated peritoneal dialysis (APD).

• The European Renal Association (ERA) reported that nearly 25% of dialysis patients in Europe are shifting to home-based dialysis, boosting demand for peritoneal dialysis devices.

Download Free Sample to learn more about this report

PERITONEAL DIALYSIS MARKET SEGMENTATION

The peritoneal dialysis market is segmented by product type and treatment application. Product categories include peritoneal dialysis machines, dialysis solutions, and supporting equipment such as catheters, transfer sets, tubing, and accessories. Solutions lead product demand because sterile dialysate is required for every treatment exchange. Applications include continuous ambulatory peritoneal dialysis, automated peritoneal dialysis, and other supervised or hybrid approaches. Continuous ambulatory treatment remains established in cost-sensitive settings, while automated therapy gains adoption through overnight treatment and connected cyclers. Product selection depends on clinical prescription, residual kidney function, lifestyle, reimbursement, training availability, infection risk, storage conditions, and local supply reliability.

By Type

According to type, the market can be segmented into Peritoneal Dialysis Machine, Peritoneal Dialysis Solution and others. The peritoneal dialysis machine is holds the majority of the market share by type segment.

• Peritoneal Dialysis Machine: Peritoneal dialysis machines account for approximately 31% of the global product market. These cyclers automatically control filling, dwelling, and draining during automated peritoneal dialysis. Modern systems are designed for home operation and can guide users through setup, connection, treatment, and disconnection. Digital displays, audible alarms, prescription management, treatment records, and remote data transfer improve therapy supervision. Manufacturers are reducing device weight, operating noise, and setup complexity to support travel and independent use. Equipment demand is concentrated in markets with established reimbursement, home-training programs, reliable electricity, technical service, and continuous consumable supply. Connected machines are gaining preference because clinicians can evaluate treatment performance without waiting for an in-person review. 

• Peritoneal Dialysis Solution: Peritoneal dialysis solutions represent approximately 55% of global product demand. Sterile fluid is introduced into the abdominal cavity to remove waste products and excess water through the peritoneal membrane. Conventional solutions commonly use glucose to establish an osmotic gradient, while alternative formulations may support extended dwell periods or individualized fluid management. Demand is recurring because each patient requires multiple solution bags according to the prescribed treatment schedule. Product quality depends on sterility, electrolyte composition, glucose concentration, packaging integrity, connector compatibility, and dependable distribution. Manufacturers are developing neutral-pH, low glucose-degradation-product, amino-acid, and icodextrin-based solutions for selected clinical requirements.

• Others: Other products contribute approximately 14% of the peritoneal dialysis market. This category includes catheters, transfer sets, tubing, connectors, drain bags, caps, disinfecting accessories, warming equipment, scales, and patient-support materials. Although individually smaller than solutions or cyclers, these products are essential for safe therapy delivery. Catheter design affects flow performance, placement stability, comfort, and infection risk. Transfer systems must support secure connections while minimizing opportunities for touch contamination. Drain accessories help patients manage effluent safely within varied home environments. Manufacturers compete through material compatibility, intuitive handling, sterile packaging, leak resistance, and integration with established systems.

By Application

Based on application, the market can be divided into CAPD, APD and others. By the application segment, the CAPD holds the largest market share.

• CAPD (Continuous Ambulatory Peritoneal Dialysis): Continuous ambulatory peritoneal dialysis accounts for approximately 47% of application demand. CAPD does not ordinarily require an electrical cycler because patients perform manual exchanges during the day. Its simpler equipment requirements make it relevant in markets where machine affordability, electricity reliability, or technical service availability remains limited. CAPD also provides schedule flexibility, although patients must accommodate repeated exchanges and follow strict aseptic procedures. Demand centers on dialysis solutions, transfer sets, connectors, drain bags, and infection-prevention supplies. The method can support broad access when healthcare systems invest in catheter services, patient training, and dependable fluid distribution.

• APD (Automated Peritoneal Dialysis): Automated peritoneal dialysis represents approximately 46% of application demand and is the fastest-evolving treatment category. APD uses a programmable cycler to perform exchanges, usually overnight, allowing patients to complete much of their prescribed therapy while sleeping. This approach can offer daytime freedom and may suit employed adults, students, caregivers, and patients requiring tailored exchange patterns. Connected systems permit remote review of treatment data and support clinical intervention when adherence or drainage problems appear. Market demand includes cyclers, disposable sets, solution bags, software, technical service, and home-delivery programs. Adoption depends on reimbursement, patient suitability, training, electricity, storage space, and dependable device support.

• Others: Other applications account for approximately 7% of peritoneal dialysis demand. This segment includes intermittent peritoneal dialysis, assisted treatment, urgent-start programs, pediatric protocols, and specialized clinical regimens. Assisted peritoneal dialysis allows trained caregivers or healthcare personnel to help patients who cannot independently complete exchanges. It can expand home therapy among older adults, people with limited mobility, and patients with visual or cognitive difficulties. Urgent-start pathways can offer an alternative to temporary hemodialysis access when clinical conditions and catheter placement permit. Pediatric treatment requires precise prescriptions, appropriate fill volumes, family education, and specialized monitoring.

MARKET DYNAMICS

Driving Factor

Expanding preference for home-based kidney replacement therapy

Home-based treatment is the primary driver of peritoneal dialysis market growth. The therapy allows suitable patients to perform prescribed exchanges without traveling to a hemodialysis center several times each week. This flexibility can support employment, education, caregiving, travel, and greater control over daily schedules. Automated peritoneal dialysis further improves convenience because the principal exchanges are generally completed during sleep. Healthcare systems are promoting home modalities to reduce pressure on dialysis facilities and align treatment with patient preferences. Home therapy contributes approximately 61% of emerging product demand across the market. Growth also depends on earlier modality education, timely catheter placement, coordinated discharge planning, and access to trained peritoneal dialysis nurses. Manufacturers supporting these programs with reliable cyclers, solutions, delivery services, training materials, and remote monitoring can strengthen adoption.

• According to the World Health Organization (WHO), end-stage renal disease affects over 2 million people worldwide, with peritoneal dialysis being a critical treatment alternative.

• The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) highlighted that 1 in 7 adults in the U.S. suffers from kidney disease, significantly increasing the need for dialysis.

Driver Impact Analysis*

Restraining Factor

Risk of peritonitis and treatment discontinuation

Peritonitis remains an important restraint because infection can cause abdominal pain, cloudy effluent, hospitalization, membrane damage, technique failure, or conversion to hemodialysis. Treatment requires patients or caregivers to follow careful hand hygiene, connection, storage, and exchange procedures. Concerns related to peritonitis influence approximately 38% of treatment decisions within the market. Exit-site infections, catheter malfunction, leaks, hernias, inadequate ultrafiltration, and glucose exposure create additional clinical concerns. Some patients may also find repeated exchanges physically or emotionally burdensome. Manufacturers and providers address these barriers through closed connection systems, improved transfer sets, antimicrobial protocols, structured training, retraining, and rapid clinical support. Nevertheless, uneven nursing capacity and limited patient follow-up can reduce therapy retention, particularly in regions where specialist services and home visits remain difficult to access.

• The International Society for Peritoneal Dialysis (ISPD) estimates that around 20–30% of peritoneal dialysis patients experience peritonitis annually, which restricts adoption.

• According to the Canadian Institute for Health Information (CIHI), hospital readmission rates for dialysis patients exceed 35%, reflecting complications that slow peritoneal dialysis acceptance.

Restraint Impact Analysis*

Integration of remote monitoring with automated peritoneal dialysis

Opportunity

Connected automated peritoneal dialysis creates a significant opportunity for equipment manufacturers, software developers, dialysis providers, and home-care organizations. Remote platforms can transfer treatment information from cyclers to clinical teams, allowing clinicians to review adherence, completed exchanges, ultrafiltration, alarms, and interruptions. Approximately 44% of current equipment upgrades include some form of connected functionality. Timely data can help care teams identify technical problems, contact patients, adjust prescriptions, and reduce unnecessary clinic visits. Future platforms may incorporate predictive alerts, patient messaging, inventory management, education modules, and integration with electronic health records.

Maintaining reliable training and consumable supply networks

Challenge

Peritoneal dialysis requires more than a machine and prescribed solution. Successful therapy depends on catheter placement, patient selection, practical training, home storage, scheduled deliveries, technical support, and access to clinical advice. Training limitations affect approximately 29% of potentially eligible patients in underdeveloped home-dialysis programs. Consumables are used continually, making production quality, sterile packaging, inventory planning, and last-mile distribution essential. Supply disruption can threaten treatment continuity because patients cannot safely substitute unapproved fluids or connection products. Rural locations, severe weather, transportation difficulties, and limited warehouse capacity add complexity.

• Download Free Sample to learn more about this report

•  

PERITONEAL DIALYSIS MARKET REGIONAL INSIGHTS

North America Dominates The Market Due To The Presence Of Key Market Players

In North America, people suffering from chronic kidney disease have increased significantly due to the rising prevalence of diabetes and high blood pressure. Additionally, a growing percentage of kidney patients necessitate regular dialysis treatment. As a result, the peritoneal dialysis market is dominated by North America owing to the presence of key market players which include both governments and private parties who are investing considerably in the development of cutting-edge medical devices in the region.  After North America, the Asia Pacific region is estimated to be the second leading region over the forecast period because of the rising incidences of kidney failure and the growing geriatric population in the region.

• North America

North America accounts for approximately 35% of the global peritoneal dialysis market. The region benefits from established nephrology networks, home-therapy reimbursement, trained clinical teams, and strong distribution systems. The United States is the primary contributor, while Canada also supports organized home-dialysis programs. Automated peritoneal dialysis represents nearly 58% of regional use because patients and providers increasingly value overnight exchanges and remote monitoring. Major suppliers offer cyclers, solutions, disposable sets, technical service, and home delivery. Clinical programs emphasize modality education, catheter placement, home assessment, infection prevention, and treatment retention. Regional growth is supported by policy interest in home-based kidney care. Important barriers include peritonitis, housing limitations, storage requirements, caregiver availability, and unequal access to home-dialysis training.

• Europe

Europe holds approximately 27% of the global peritoneal dialysis market. Germany, the United Kingdom, France, Italy, Spain, and Nordic countries maintain established renal-care infrastructure, although treatment patterns vary between national healthcare systems. Approximately 49% of regional peritoneal dialysis patients use automated treatment, supported by cycler availability and organized home-care services. European providers emphasize clinical quality, infection prevention, patient education, and environmentally responsible procurement. Demand includes glucose-based fluids, icodextrin solutions, cyclers, catheters, transfer sets, and monitoring platforms. Regulatory requirements encourage manufacturers to maintain strong clinical evidence, device traceability, cybersecurity, and post-market surveillance. Growth opportunities exist in assisted peritoneal dialysis for older adults and remote monitoring for geographically dispersed patients. Adoption remains constrained by workforce shortages and established dependence on facility-based hemodialysis.

• Asia-Pacific

Asia-Pacific represents approximately 26% of the global peritoneal dialysis market. The region combines high-volume healthcare systems, large kidney failure populations, expanding insurance coverage, and significant differences in treatment access. China, Japan, India, Australia, South Korea, and Southeast Asian countries are important demand centers. CAPD accounts for approximately 56% of regional application demand because manual treatment can be implemented without cycler infrastructure. China-based manufacturers strengthen regional solution production, while multinational suppliers provide machines, fluids, and connected services. Governments and providers increasingly evaluate home dialysis as a way to address limited center capacity and travel burdens. Expansion requires affordable products, nephrology training, catheter services, infection-control education, and dependable logistics. Rural access, household storage, affordability, and variable reimbursement remain significant barriers.

• Middle East & Africa

Middle East and Africa account for approximately 7% of the global peritoneal dialysis market. Gulf countries possess modern hospital infrastructure and purchasing capacity, while many African markets face limited nephrology services and dependence on imported products. CAPD represents nearly 63% of regional peritoneal dialysis use because it requires less machine infrastructure than automated therapy. Peritoneal dialysis may support patients living far from hemodialysis centers, but successful deployment depends on clean water, safe housing, clinical training, catheter placement, and uninterrupted solution supply. Regional opportunities include local fluid manufacturing, public procurement, home-care pilots, and clinician education. Challenges include limited reimbursement, shortages of nephrologists and dialysis nurses, transportation difficulties, and inconsistent product availability. Partnerships between governments, hospitals, suppliers, and nonprofit organizations can improve sustainable access.

• Rest of the World

The Rest of the World represents approximately 5% of the global peritoneal dialysis market. Latin America contributes a significant portion through Brazil, Mexico, Argentina, Colombia, and neighboring healthcare systems. CAPD accounts for nearly 59% of demand because manual therapy remains accessible in locations with limited cycler availability. Regional development is supported by public dialysis programs, improving kidney disease awareness, and local solution production. Automated systems are expanding among insured urban patients and established private providers. Market requirements include affordable fluids, reliable catheter supply, clinician training, home delivery, and infection-monitoring programs. Currency volatility, imported equipment costs, uneven reimbursement, and geographic distance complicate distribution. Local manufacturing, telehealth, assisted therapy, and public-private partnerships provide opportunities to strengthen home-dialysis availability.

KEY INDUSTRY PLAYERS

Competition includes multinational renal-care companies and regional manufacturers specializing in peritoneal dialysis solutions, machines, catheters, and disposable accessories. Baxter and Fresenius maintain broad positions through integrated product portfolios, clinical support, distribution networks, and connected therapy capabilities. B. Braun and Terumo contribute healthcare manufacturing expertise, while Chinese companies serve expanding domestic and export demand. Regional participants compete through affordability, local production, hospital relationships, and responsive distribution. Strategic priorities include remote monitoring, simplified cyclers, biocompatible fluids, infection-prevention systems, and dependable home delivery. Partnerships with hospitals, nephrology networks, software providers, and public health programs help companies expand treatment access and improve patient support.

List of Top Peritoneal Dialysis Companies

• Baxter (U.S.)
• Fresenius (Germany)
• B. Braun (Germany)
• Terumo (Japan)
• Huaren (China)
• CR Double-Crane (China)
• Qingshan Likang (China)
• Tj Tianan (U.S.)
• Renax (U.S.)
• Medionics (Canada)
• Bluesail (China)

MARKET LEADERSHIP MATRIX: PERITONEAL DIALYSIS MARKET

LEADER INSIGHTS

• Baxter: José (Joe) E. Almeida, Chairman, President and Chief Executive Officer of Baxter, has emphasized the increasing global need for advanced renal care solutions, driven by rising chronic kidney disease prevalence, aging populations, and the demand for accessible home-based treatment options. His strategic outlook highlights continued investment in renal therapies, innovation, and patient-centered care models that support long-term expansion opportunities in dialysis markets, including peritoneal dialysis. (Published: February 6, 2025 | Source: https://investor.baxter.com/financial-information/quarterly-results)

• Fresenius Medical Care: Helen Giza, Chief Executive Officer of Fresenius Medical Care, has highlighted the importance of expanding patient access to innovative kidney care solutions and improving treatment outcomes through technology-enabled healthcare delivery. Her comments reflect the company’s focus on transforming renal care, increasing adoption of home dialysis approaches, and investing in solutions that address the growing global demand for chronic kidney disease management. (Published: February 20, 2025 | Source: https://freseniusmedicalcare.com/en/investors/financial-results/)

• B. Braun: Anna Maria Braun, President and Chief Executive Officer of B. Braun, emphasized that demographic changes, increasing healthcare needs, and advancements in medical technology are creating long-term growth opportunities for healthcare solutions. Her strategic vision highlights continued innovation, investment in medical devices, and development of integrated care solutions that support improved treatment accessibility and evolving renal care requirements. (Published: April 2025 | Source: https://www.bbraun.com/en/company/press-and-media/annual-report.html)

Investment Analysis and Opportunities

Investment is concentrating on connected cyclers, solution production, catheter services, home-delivery infrastructure, and clinical training. Approximately 42% of current strategic investment targets digital monitoring and data-enabled patient support. Emerging markets offer opportunities for local dialysis-fluid manufacturing because recurring solution requirements create dependable demand. Investors can also support urgent-start pathways, assisted peritoneal dialysis, telehealth, and community nursing. Companies developing compact cyclers, safer connectors, biocompatible fluids, and predictive software can address unmet clinical needs. Public-private partnerships may expand treatment in regions with limited hemodialysis capacity. Successful investment requires regulatory expertise, sterile manufacturing capability, cybersecurity controls, reliable logistics, and long-term collaboration with nephrology providers.

New Product Development

Product development emphasizes lighter cyclers, guided setup, quieter operation, remote monitoring, and simplified disposable connections. Approximately 41% of current development programs prioritize digital connectivity and treatment-data exchange. Solution innovation includes neutral-pH fluids, reduced glucose-degradation products, icodextrin formulations, and packaging designed for easier handling. Infection-prevention development covers closed connectors, improved transfer sets, antimicrobial materials, and touch-contamination safeguards. Digital platforms increasingly support prescription transfer, adherence review, alarm analysis, education, and inventory management. Manufacturers are also evaluating recyclable packaging and reduced-material consumables. New products must balance patient convenience with sterility, accuracy, cybersecurity, clinical reliability, regulatory compliance, and compatibility across machines, solutions, and supporting accessories.

Five Recent Developments (2023–2025)

• March 2025: Baxter Connected home dialysis platform strengthens remote treatment visibility and clinical coordination. Baxter advanced remote therapy monitoring to improve clinician oversight, using connected cycler data, treatment records, adherence review, and secure prescription-management capabilities for home patients.
• June 2025 : B. Braun Expanded renal-care automation supports safer preparation and more efficient clinical workflows. B. Braun enhanced automated dialysis capabilities using closed-system processing, intelligent identification, validated measurement, and safety controls to reduce handling complexity and operational errors.
• September 2025: Terumo Patient-focused catheter development strengthens access reliability for home peritoneal dialysis treatment. Terumo advanced catheter and connection capabilities to support dependable flow, secure placement, biocompatibility, infection prevention, and simplified handling across home-care treatment pathways.
• March 2026 : Fresenius Artificial intelligence research advances personalized selection for home dialysis treatment pathways. Fresenius applied machine-learning methods to assess home-dialysis utilization predictors, supporting individualized modality selection, shared clinical decisions, precision care, and improved patient engagement.
• July 2026 : Huaren Expanded sterile dialysis-solution capability supports broader domestic and export market availability. Huaren strengthened fluid manufacturing and quality-control capacity to improve sterile production, packaging integrity, supply continuity, formulation consistency, and regional peritoneal dialysis access.

Report Coverage of Peritoneal Dialysis Market

The peritoneal dialysis market report covers machines, solutions, catheters, transfer sets, accessories, and supporting digital services. It evaluates CAPD, APD, and other clinical applications across 5 geographic regions whose shares total 100%. The analysis examines home-treatment adoption, infection prevention, remote monitoring, reimbursement, patient training, catheter access, consumable distribution, and regulatory conditions. Competitive coverage includes multinational suppliers and regional manufacturers, with attention to product portfolios, partnerships, investment priorities, and technology positioning. The report also assesses solution innovation, connected cyclers, assisted therapy, urgent-start programs, sustainable packaging, and supply-chain requirements influencing manufacturers, healthcare providers, distributors, investors, and procurement organizations.